About
Dr. Srikanth Sola is CEO of Devic Earth, a greentech company specializing in air pollution control equipment. He also serves as Honorary Senior Consultant cardiologist at the Sri Sathya Sai Institute of Higher Medical Sciences (SSSIHMS) in Bangalore. Dr. Sola's research includes active funding from the Department of Biotechnology (India), Ministry of Environment, Forests, and Climate Change (India), National Institutes of Health (USA), and other sources. He has published in the Journal of American College of Cardiology, Circulation, JACC Cardiovascular Imaging, European Heart Journal, and others. He has served on the editorial board of several journals and a reviewer for Circulation, JACC, JACC Cardiovascular Imaging, Journal of the Society of Cardiovascular Computed Tomography, and other journals in his specialty.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- Impact of surgical ventricular restoration on ventricular shape, wall stress, and function in heart failure patients Save
- Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use Save
- Extent of thoracic aortic atheroma burden and long-term mortality after cardiothoracic surgery: a computed tomography study. Save
- Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement Save
- Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: A delayed contrast enhanced MRI study Save
- Cardiovascular MRI: What cardiologists need to know Save
- Evaluation of constrictive pericarditis by 64-slice multi-detector computed tomography Save
- MRI of the heart: Promises fulfilled? Save
- Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study Save
- Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome Save